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The earliest retrograde activation during sinus rhythm-guided for left posterior
fascicular ventricular tachycardia ablation: role of the new mapping in an
attempt to improve procedural effectiveness
Li Xuping1, Feifan Ouyang1,2, Zhou shenghua1
1Central South University of Xiangya Er Hospital, 2Asklepios Klinik St. Georg,
Lohmühlenstraße 5, Hamburg, Germany
Objectives: To investigate whether the earliest retrograde activation during sinus
rhythm -guided for left posterior fascicular ventricular tachycardia ablation further
contributes to the identiﬁcation of critical sites of VT reentry and whether this
translates into a more effective ablation outcome in a cohort of patients undergoing
VT ablation.
Methods: This study retrospectively analyzed 86 consecutive patients (mean age
36.35.9 years) referred for catheter ablation of electrocardiographically docu-
mented LPF VT. Programmed stimulation was performed to induce tachycardia,
while mapping and ablation was aided by use of a 3D electroanatomical map-
ping system. Catheter ablation targeted the earliest potential suggestive of
retrograde activation within the posterior Purkinje ﬁber network (retro-PP)
recorded along the posterior mid-septal left ventricle during SR if LPF VT was
noninducible.
Results: 80 patients (45 men; mean age 349 years) had inducible VTs. The mean
tachycardia cycle length was 31533 ms. Overall, 75/86 (87%) patients underwent
successful catheter ablation in SR targeting the earliest retro-PR. In none of the pa-
tients, ablation resulted in LPF block. No procedure-related complications occurred.
Ablation was successful in all. After a median follow-up period of 2.9 (0.8-5.9) years,
81/86 (94%) patients were free from recurrent VT.
Conclusions: In patients presenting with LPF VT, ablation of the earliest retro-PP
along the posterior mid-septal LV during SR results in excellent long-term outcome
during a median follow-up period of almost 2.9 years.
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Inﬂuence of angiotensin-converting enzyme gene insertion/deletion
polymorphism on occurrence and recurrence of atrial ﬁbrillation: A systematic
review and Meta-analysis
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Objectives: This meta-analysis was to explore the inﬂuence of angiotensin-converting
enzyme gene insertion/deletion (ACE I/D) polymorphism on atrial ﬁbrillation (AF)
occurrence and recurrence.
Methods: Case-control or cohort studies evaluating the association between ACE I/D
polymorphism with AF risk and its recurrence after catheter ablation were searched in
electronic databases. Meta-analyses were performed by reviewing 15 studies for AF
occurrence and 2 studied for AF recurrence. Odds ratio (OR) and 95% conﬁdence
interval (CI) were used to evaluate. Statistical analysis was performed with Review
Manager 5.2 and Stata 11.0.
Results: A total of 1981 AF patients and 3837 controls obtained from 15 case-
control studies were included. There were 6 studies involving Caucasians and 9
studies involving Asians. The combined results showed signiﬁcant associations in
recessive model [DD versus ID+II], heterozygote comparison (DD versus ID),
homozygote comparison (DD versus II) and multiplicative model (D versus I) on
the basis of all studies. On subgroup analysis by ethnicity, similarly outcomes were
also identiﬁed in recessive model and heterozygote comparison (DD versus ID) in
both Caucasians and Asians, while homozygote comparison and multiplicative
model lost part association. In the meta-analysis involving 145 AF recurrence cases
and 285 AF non-recurrence cases obtained from 2 cohort studies, genotype DD
signiﬁcantly increased the risk of AF recurrence after catheter ablation under the
recessive model.
Conclusions: Our investigations demonstrate that ACE I/D polymorphism is asso-
ciated with increasing the risk of AF occurrence and recurrence. The genotype DD of
ACE gene is a risk factor.
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Treatment of Ventricular Tachycardia with Structural Heart Disease by
Substrate Modiﬁcation Ablation guided with 3-dimensional mapping system
in 7 Patients
Tang Cheng, Zhang Jinlin, Su Xi
Wuhan Asia Heart Hospital
Objectives: To investigate the methods, electrophysiological characteristics and the
treatment outcomes of ventricular tachycardia (VT) with structural heart disease byJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Csubstrate modiﬁcation ablation under the guidance of contact 3-dimensional mapping
system.
Methods: From 2013 May to 2014 March, Seven patients with structural heart disease
(4 patients with dilated cardiomyopathy, 2 patients with ischemic cardiomyopathy, 1
patient with arrhythmogenic right ventricular cardiomyopathy) with recurrent VT
attack (3 cases with syncope) underwent cardiac electric reconstruction by the guid-
ance of contact 3-dimensional mapping system. The scar area was arbitrarily deﬁned
as<0.5 mV (ventricular bipolar voltage). To mark late ventricular potential during
sinus rhythm along with diastolic potential during VT in and around scar tissue. The
areas with special potential, as mentioned above, underwent saline-irrigated catheter
ablation (35-40W, 43C, 17ml/min) in ﬂake radiofrequency ablation until the special
potential disappeared. Before the end of ablation, programmed ventricular stimulation
was repeated to induce no clinical VT deﬁnitely.
Results: All seven patients were mapped the low voltage area (1 case in the
epicardial surface, 6 cases in the endocardial surface). The low voltage area
(6.0-85.5 (31.017.7) cm2) occupied 5.4-25.1(14.55.2) of the ventricular area.
Late ventricular potential could be marked during sinus rhythm in and around low
voltage area. Among seven patients, 12 VTs were induced during the procedure
(2 VTs originating from right ventricle, 10 VTs originating from left ventricle).
Ventricular diastolic potential could be recorded during VT attack. All seven pa-
tients were completed ablation successfully (1 case appeared ventricular ﬁbrillation
and then given electrical cardioversion). The success rate of immediate substrate
modiﬁcation ablation was 100 %( ablation points 19-331 (112.762.4), ablation
time 120-240 (159.337.6) min). Only 3 patients accepted ICD implantation post
ablation because of charge and will. During the follow-up 1-11 months, 1 patient
who accepted ICD implantation died of sudden cardiac arrest, the others didn’t
appeared VT.
Conclusions: The treatment outcome of substrate modiﬁcation ablation under the
guidance of contact 3-dimensional mapping system is effective and safe for patients of
VT with structural heart disease.
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Initial application experience of a new multi-polar saline-irrigated mapping and
ablation catheter
Liu Jun1, Yan Kaufmann2, Charalampos Kriatselis2, Eckart Fleck2,
Gerds-Li Jinhong2, Pihua Fang1, Shu Zhang1
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Objectives: To investigate the safety and validity of a new muti-polar saline-irrigated
mapping and ablation catheter (nMARQ) for pulmonary vein isolation(PVI).
Methods: Nine patients with symptomatic atrial ﬁbrillation were received ablation
with the nMARQ catheter. After waiting for 15 minutes when PVI was archived
by the nMARQ catheter, PVI was rechecked by a Lasso mapping catheter.
Additional ablation with the nMARQ catheter was redo if there was a gap con-
duction between pulmonary vein (PV) and left atrium. The time of the mapping
and ablation of each PV, the X ray exposure, the ablation release mode and the
acute PVI were recorded.
Results: A total of 130 times ablation were released on the 33 PVs with mean 3.9
times ablation per PV, including 44 times (33.8%) on LSPV, 38 times (29.2%) on
LIPV, 24 times (18.5%) on RSPV, 24 times (18.5%) on RIPV. Energy released by
full polars or selected polars took half and half. After 15 minutes waiting after
PVI by the nMARQ catheter, conduction recovered. On 5 PVs (all LIPV). The
mean time of the PV mapping, the ablation, the whole procedure, the whole
mapping, the total ablation time, the X ray exposure time were 9.9 minutes,
3.6 minutes, 134 minutes, 37 minutes, 13 minutes, 21 minutes. The mean of X ray
exposure dosage was 35460 mGy/cm2. A total of 18 times of esophagus tem-
perature alarm, including 4 times (9.1%) on LSPV, 10 times (26.3%) on LIPV,
4 times (16.7%) on RIPV. The success rate of PVI was 93.9% after ablation. No
procedure related complications occurred during the ablation procedure and the
inpatient period.
Conclusions: PVI can archived by the nMARQ catheter safely and effectively with a
higher success rate.
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The early status of warfarin management in patients with atrial ﬁbrillation after
catheter ablation
Tang Lihong, Xue Yu-Mei, Wu Shu-Lin, Deng Hai, Huang Jun, Zhan Xian-Zhang,
Fang Xian-Hong, Liao Hong-Tao, Wei Wei, Liu Yang, Liao Zi-Li
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Cardiology
Objectives: To analyze the anticoagulation management status in patients undergoing
atrial ﬁbrillation (AF) ablation and were treated with warfarin.
Methods: Five hundred and ten patients with nonvalvular AF (NVAF) undergoing
catheter ablation were retrospectively analyzed. All the patients discontinued warfarin
before ablation procedure and used low molecular weight heparin (LMWH) to
“bridge” anticoagulation before and after ablation. The International Normalized Ratio
(INR) was recorded at the 1st week, 2nd week, 3rd week, 4th week, 2nd month, and 3rd
month. Time in therapeutic range (TTR) was assessed.
Results: A total of 510 patients (64.7% male) with NVAF underwent 2669 INR
measurements within 3 months. The mean age was 57.8 11.0 years and the meanardiovascular Disease Clinical Research C163
